New York's Office of Cannabis Management (OCM) is being sued by the Coalition for Access to Regulated and Safe Cannabis (CARSC), for allegedly violating the Marijuana Regulation and Taxation Act (MRTA).
What happened
In the complaint, filed Thursday in Albany County Supreme court, the coalition argues unconstitutional actions that put New Yorkers’ health and safety at risk, writes Syracuse.com.
The group alleges that both OCM and the Cannabis Control Board (CCB) violated the legalization law when they reserved the first 150 adult-use retail licenses for social equity applicants. CARSC is now asking a judge to order state lawmakers to open up licensing for all retail dispensary applicants immediately.
What is CARSC?
The coalition describes itself as an “unincorporated trade association” comprised of organizations and physicians whose practices were negatively affected because of the state’s “neglect” of its medical marijuana program and parties that were seeking to acquire a dispensary license.
According to Syracuse.com, at least four large cannabis companies are part of the group, including Acreage Holdings ACRHF, Curaleaf Holdings Inc CURLF, Green Thumb Industries Inc GTBIF, and PharmaCann.
As per a memo filed with the lawsuit, the regulatory cannabis boards “overstepped their rule-making authority,” and as a result, it “indefinitely postponed the licensing of the hundreds of additional dispensaries necessary to satisfy consumer demand and to displace the illicit markets.”
“Rather than perform the tasks required by the MRTA – which would promote a safe and regulated cannabis industry for medical patients and adult-use consumers alike – CCB and OCM have improperly assumed the role of the Legislature to impose their own policies over those of New York’s elected officials and, by extension, their constituents,” the lawsuit alleges.
Photo: Benzinga edit with images by Kindel Media on Pixabay and Quintin Gellar on Pexels
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.